CCL11 (eotaxin-1): A new diagnostic serum marker for prostate cancer

Molecular pathology of prostate cancer

(2017) L.H. Cazares et al.   Cancer Biomarkers

CXCL5 Promotes Prostate Cancer Progression

(2015) Lesa A Begley et al.   NEOPLASIA

CCL2 and CCL3 are essential mediators of pelvic pain in experimental autoimmune prostatitis

(2012) Marsha L. Quick et al.   AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY

Emerging Critical Role of Molecular Testing in Diagnostic Genitourinary Pathology

(2012) George J. Netto et al.   ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE

The CXCL12/CXCR4 axis promotes ligand-independent activation of the androgen receptor

(2012) Sathish Kasina et al.   MOLECULAR AND CELLULAR ENDOCRINOLOGY

Prognostic Determinants in Prostate Cancer

(2011) Neil E. Martin et al.   CANCER JOURNAL

Missing the Mark on Prostate-Specific Antigen Screening

(2011) David C. Miller et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

An integrated proteomic approach to identifying circulating biomarkers in high-risk neuroblastoma and their potential in relapse monitoring

(2011) Rachel A. Egler et al.   Proteomics Clinical Applications

Urine TMPRSS2:ERG Fusion Transcript Stratifies Prostate Cancer Risk in Men with Elevated Serum PSA

(2011) S. A. Tomlins et al.   Science Translational Medicine

Serum Signature of Hypoxia-Regulated Factors Is Associated with Progression after Induction Therapy in Head and Neck Squamous Cell Cancer

(2010) L. A. Byers et al.   MOLECULAR CANCER THERAPEUTICS

ADAM-mediated amphiregulin shedding and EGFR transactivation

(2009) S. Kasina et al.   CELL PROLIFERATION

Screening and Prostate-Cancer Mortality in a Randomized European Study

(2009) Fritz H. Schröder et al.   NEW ENGLAND JOURNAL OF MEDICINE

The inflammatory microenvironment of the aging prostate facilitates cellular proliferation and hypertrophy

(2008) L.A. Begley et al.   CYTOKINE

Prostate-cancer mortality in the USA and UK in 1975–2004: an ecological study

(2008) Simon M Collin et al.   LANCET ONCOLOGY

Pilot and feasibility study of serum chemokines as markers to distinguish prostatic disease in men with low total serum PSA

(2008) Jill A. Macoska et al.   PROSTATE